Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK1 | Q13546 | 5/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | SMURF1 | Q9HCE7 | 1/20 | 0.33 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.32 |
| ▸ | HCAR1 | Q9BXC0 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.32 |
| ▸ | GRM5 | P41594 | 1/20 | 0.32 |
| ▸ | MET | P08581 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17427478 | 0.84 | LMNA (0.39) | LMNACHRM4GAAKMT2AMAP3K5 | |
| SCHEMBL16022005 | 0.84 | POLB (0.44) | RIPK1LMNAKMT2AMEN1SMURF1 | |
| SCHEMBL17427483 | 0.83 | RIPK1 (0.36) | RIPK1LMNAKMT2AMEN1HCAR1 | |
| SCHEMBL17427486 | 0.81 | CTDSP1 (0.39) | RIPK1KMT2AMEN1CTDSP1POLB | |
| SCHEMBL17427356 | 0.78 | POLB (0.48) | RIPK1LMNAKMT2AMEN1SMURF1 | |
| SCHEMBL16022003 | 0.77 | HCAR1 (0.40) | LMNAGAAKMT2AMEN1HCAR1 | |
| SCHEMBL16022024 | 0.76 | SMN1; SMN2 (0.40) | LMNAPOLB | |
| SCHEMBL17427479 | 0.71 | POLB (0.47) | LMNAGAAKMT2APOLBMET | |
| SCHEMBL17427489 | 0.70 | PDE4A (0.38) | LMNAKMT2AMEN1MET | |
| SCHEMBL16022018 | 0.70 | AXL (0.37) | LMNAGAAMET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160009693-A1 | HERBICIDAL COMPOUNDS | SYNGENTA LIMITED (GB) | 2016-01-14 | — | — | US | disclosed |
| US-20160009693-A1 | HERBICIDAL COMPOUNDS | SYNGENTA LIMITED (GB) | 2016-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160009693-A1 | HERBICIDAL COMPOUNDS | DDT, HAX1, CYP4X1 | RIPK1 4417/4885LMNA 3606/4885CHRM4 627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.